Literature DB >> 4606330

Chemical debridement of burns.

S M Levenson, D Kan, C Gruber, L V Crowley, R Lent, A Watford, E Seifter.   

Abstract

The development of effective, non-toxic (local and systemic) methods for the rapid chemical (enzymatic and non-enzymatic) debridement of third degree burns would dramatically reduce the morbidity and mortality of severely burned patients. Sepsis is still the major cause of death of patients with extensive deep burns. The removal of the devitalized tissue, without damage to unburned skin or skin only partially injured by burning, and in ways which would permit immediate (or very prompt) skin grafting, would lessen substantially the problems of sepsis, speed convalescence and the return of these individuals to society as effective human beings, and would decrease deaths. The usefulness and limitations of surgical excision for patients with extensive third degree burns are discussed. Chemical debridement lends itself to complementary use with surgical excision and has the potential advantage over surgical excision in not requiring anesthesia or a formal surgical operation. The authors' work with the chemical debridement of burns, in particular the use of Bromelain, indicates that this approach will likely achieve clinical usefulness. The experimental studies indicate that rapid controlled debridement, with minimal local and systemic toxicity, is possible, and that effective chemotherapeutic agents may be combined with the Bromelain without either interfering with the actions of the other. The authors believe that rapid (hours) debridement accomplished by the combined use of chemical debriding and chemotherapeutic agents will obviate the possibility of any increase in infection, caused by the use of chemical agents for debridement, as reported for Paraenzyme(21) and Travase.(39,48) It is possible that the short term use of systemic antibiotics begun just before and continued during, and for a short time after, the rapid chemical debridement may prove useful for the prevention of infection, as appears to be the case for abdominal operations of the clean-contaminated and contaminated types.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4606330      PMCID: PMC1344165          DOI: 10.1097/00000658-197410000-00032

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  48 in total

1.  ENZYMATIC DEBRIDEMENT OF THIRD DEGREE BURNS IN ANIMALS WITH BROMELAINS. A PRELIMINARY REPORT.

Authors:  G K KLEIN
Journal:  J Maine Med Assoc       Date:  1964-09

2.  Large scale purification of proteinases from Clostridium histolyticum filtrates.

Authors:  D A CONKLIN; M E WEBSTER; P L ALTIERI; S BERMAN; J P LOWENTHAL; R B GOCHENOUR
Journal:  J Bacteriol       Date:  1961-10       Impact factor: 3.490

3.  Acid debridement of burned rats and men.

Authors:  N S GIMBEL; F WEISSMAN; J SCHIRLE; A U ORTEN
Journal:  Am J Surg       Date:  1960-05       Impact factor: 2.565

4.  Enzymatic treatment of deep burns. Experience with a new preparation: ethizyme.

Authors:  S O LILJEDAHL; M BACKDAHL
Journal:  Acta Chir Scand       Date:  1960-04-14

5.  A clinical evaluation of enzymatic debridement with papain-urea-chlorophyllin ointment.

Authors:  J F BURKE; T GOLDEN
Journal:  Am J Surg       Date:  1958-05       Impact factor: 2.565

6.  Chemicals and enzymes in debridement of thermal burns.

Authors:  R D SAUTTER; J A BUCKWALTER; S E ZIFFREN
Journal:  AMA Arch Surg       Date:  1958-05

7.  The Pyruvic Acid Method of Burn Slough Removal: An Experimental Investigation.

Authors:  C R Lam; M Puppendahl
Journal:  Ann Surg       Date:  1945-06       Impact factor: 12.969

8.  Laser excision of acute third-degree burns followed by immediate autograft replacement: an experimental study in the pig.

Authors:  S Stellar; N Levine; R Ger; S M Levenson
Journal:  J Trauma       Date:  1973-01

9.  Burns in my lifetime.

Authors:  C P Artz
Journal:  J Trauma       Date:  1969-10

10.  A clinical trial of a desloughing agent in burns. A preliminary report.

Authors:  B S Crawford; L Rozner
Journal:  Br J Plast Surg       Date:  1966-04
View more
  2 in total

1.  Microcrystalline collagen hemostat (MCCH) and wound healing.

Authors:  A Schittek; A A Demetriou; E Seifter; J M Stein; S M Levenson
Journal:  Ann Surg       Date:  1976-12       Impact factor: 12.969

2.  Historical Perspectives on the Development of Current Standards of Care for Enzymatic Debridement.

Authors:  Wolfram Heitzmann; Paul Christian Fuchs; Jennifer Lynn Schiefer
Journal:  Medicina (Kaunas)       Date:  2020-12-17       Impact factor: 2.430

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.